BIOMAT Database Logo BIOMAT Database Logo

Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity. 2013

Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
INSERM, U892, CRCNA, Nantes, France.

Acne is a chronic inflammatory illness of the pilosebaceous follicle where innate immunity plays a central role. In acne, the density of Propionibacterium acnes is increased in the pilosebaceous unit. We hypothesized that the severity of acne is not only dependent on the proliferation of P. acnes but also dependent on the pro-inflammatory potential of P. acnes strains and consequently constitutes potential triggering factor for acne scarring. We investigated pro-inflammatory potential of five different strains of P. acnes and P. avidum in skin explants and the preventive effect of zinc gluconate. The expression of immune markers was studied by immunohistochemistry, RT-qPCR and ELISA. P. acnes strains modulate differently the expression of immune markers both at gene and at protein levels. P. acnes type III had the highest pro-inflammatory potential by up-regulating the expression of PAR-2, TNF-alpha, MMP-13 and TIMP-2, whereas P. avidum had the weakest by up-regulating only MMP-13 and TIMP-2. Preincubation of zinc gluconate, which is a modulator of innate immunity, down-regulates the expression of most immune markers induced by P. acnes, PAR-2, TIMP-2, up-regulates MMP-1, TIMP-1. Our results demonstrate that different P. acnes strains have different inflammatory potential targeting markers of cutaneous innate immunity, and that inflammatory potential can be down-regulated by zinc gluconate. As such, the inflammatory potential of P. acnes strains on acne skin may influence the severity of inflammatory acne lesions and scars.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D011425 Propionibacterium acnes A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants. Corynebacterium acnes,Corynebacterium parvum
D005942 Gluconates Derivatives of gluconic acid (the structural formula HOCH2(CHOH)4COOH), including its salts and esters. Copper Gluconate,Gluconate, Copper
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
Biotyping and serotyping of Propionibacterium acnes strains isolated from different diagnostic materials.
August 1976, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
Letter to the Editor: Corynebacterium Parvum (Propionibacterium Acnes): Cytokines Cells, Innate Immunity, and Putative Antiviral Adoption.
March 2021, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
Propionibacterium acnes.
July 1988, BMJ (Clinical research ed.),
Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
Propionibacterium acnes.
March 2006, Letters in applied microbiology,
Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
[Disseminated Propionibacterium acnes cutaneous infection in a neutropenic patient].
October 1994, Presse medicale (Paris, France : 1983),
Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
Skin microbiota secretomes modulate cutaneous innate immunity against Borrelia burgdorferi s.s.
September 2023, Scientific reports,
Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
Dissecting the taxonomic heterogeneity within Propionibacterium acnes: proposal for Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes subsp. elongatum subsp. nov.
December 2015, International journal of systematic and evolutionary microbiology,
Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
[Strains of Propionibacterium acnes isolated from acne vulgaris (author's transl)].
January 1977, Mikrobiyoloji bulteni,
Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
January 2002, Dermatology (Basel, Switzerland),
Fiona Jasson, and Istvan Nagy, and Anne Chantal Knol, and Thomas Zuliani, and Amir Khammari, and Brigitte Dréno
Corrigendum: Proposal to reclassify Propionibacterium acnes type I as Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes type II as Propionibacterium acnes subsp. defendens subsp. nov.
November 2017, International journal of systematic and evolutionary microbiology,
Copied contents to your clipboard!